Free Trial

CVS Health (CVS) Stock Price, News & Analysis

CVS Health logo
$89.37 +0.02 (+0.02%)
Closing price 11/13/2026 03:59 PM Eastern
Extended Trading
$89.18 -0.19 (-0.21%)
As of 11/13/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About CVS Health Stock (NYSE:CVS)

Advanced

Key Stats

Today's Range
$87.63
▼
$89.92
50-Day Range
$79.90
▼
$96.80
52-Week Range
$69.51
▼
$110.68
Volume
8.02 million shs
Average Volume
11.03 million shs
Market Capitalization
$114.34 billion
P/E Ratio
10.40
Dividend Yield
2.98%
Price Target
$107.54
Consensus Rating
Moderate Buy

Company Overview

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014. Its operations primarily serve customers and patients in the United States.

AI Generated. May Contain Errors.

CVS Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
99th Percentile Overall Score

CVS MarketRank™: 
4.95914602003 of 5 stars

CVS Health scored higher than 99% of companies evaluated by MarketBeat, and ranked 2nd out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CVS Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.92, and is based on no strong buy ratings, 23 buy ratings, 2 hold ratings, and no sell ratings.

  • Upside Potential

    CVS Health has a consensus price target of $107.54, representing about 20.3% upside from its current price of $89.37.

  • Amount of Analyst Coverage

    CVS Health has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about CVS Health's stock forecast and price target.
  • Earnings Growth

    Earnings for CVS Health are expected to grow by 4.60% in the coming year, from $8.26 to $8.64 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CVS Health is 10.73, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.89.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CVS Health is 10.73, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 33.15.

  • Price to Earnings Growth Ratio

    CVS Health has a PEG Ratio of 0.78. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    CVS Health has a P/B Ratio of 1.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.41% of the float of CVS Health has been sold short.
  • Short Interest Ratio / Days to Cover

    CVS Health has a short interest ratio ("days to cover") of 2.78, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CVS Health has recently increased by 10.39%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    CVS Health pays a meaningful dividend of 2.98%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    CVS Health has only been increasing its dividend for 4 years.

  • Dividend Coverage

    The dividend payout ratio of CVS Health is 30.97%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, CVS Health will have a dividend payout ratio of 30.79% next year. This indicates that CVS Health will be able to sustain or increase its dividend.

  • Read more about CVS Health's dividend.
  • News Sentiment

    CVS Health has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 46 news articles for CVS Health this week, compared to 8 articles on an average week.
  • Search Interest

    68 people have searched for CVS on MarketBeat in the last 30 days. This is an increase of 17% compared to the previous 30 days.
  • MarketBeat Follows

    27 people have added CVS Health to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $2,001,196.00 in company stock, which represents 0.0018% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, CVS Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $2,001,196.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    0.85% of the stock of CVS Health is held by insiders.

  • Percentage Held by Institutions

    80.66% of the stock of CVS Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about CVS Health's insider trading history.
Receive CVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CVS Stock News Headlines

CVS says GLP-1s save money when priced below $350 per month
ELON + YOU + DECEMBER 8TH
Elon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th. A free Masterclass claims to reveal what Musk filed with regulators and why he's working to keep it quiet.tc pixel
CVS Health: 3 Key Takeaways for Long-Term Investors
Exterior of a CVS Pharmacy storefront with red signage, glass entrance doors, and a parking lot nearby.
CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
CVS Health beat Q3 earnings estimates and raised guidance, but shares fell 12% after it announced an unspecified 2028 split of its health services and pharmacy businesses, leaving analysts and investors awaiting more details.
Alphabet's $400 Billion Sell-Off Hides a Cloud Business That Just Doubled Revenue
Alphabet’s $400 Billion Sell-Off Could Be the Best AI Buying Window Left in 2026 (CVS)
Alphabet's 12% drop followed search and YouTube misses as Google Cloud beat. Altimetry likes Microsoft, AMD and Generac and avoids CoreWeave and Cipher Digital.
See More Headlines

CVS Stock Analysis - Frequently Asked Questions

CVS Health's stock was trading at $79.35 at the beginning of the year. Since then, CVS shares have increased by 12.6% and is now trading at $89.3670.

CVS Health Corporation (NYSE:CVS) posted its quarterly earnings results on Wednesday, November, 4th. The pharmacy operator reported $2.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.65 by $0.44. The company's quarterly revenue was up 5.4% compared to the same quarter last year.
Read the conference call transcript
.

CVS Health subsidiaries include these companies: IlliniCare Health, EntrustRX, Aetna, TargetPharmacy, Omnicare, Navarro Discount Pharmacy, Coram Specialty Infusion, and more.

CVS Health's top institutional investors include State Street Corp (4.70%), Pzena Investment Management LLC (0.81%), Assenagon Asset Management S.A. (0.35%) and Sumitomo Mitsui Trust Group Inc. (0.22%). Insiders that own company stock include Larry Robbins, Prem S Shah, Michael F Mahoney, Anne A Finucane, Edward J Ludwig, Guy P Sansone, Guy P Sansone, Tilak Mandadi, James David Clark and Steven H Nelson.
View institutional ownership trends
.

Shares of CVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CVS Health investors own include NVIDIA (NVDA), Pfizer (PFE), Johnson & Johnson (JNJ), Walt Disney (DIS), AT&T (T), Verizon Communications (VZ) and AbbVie (ABBV).

Company Calendar

Record date for 11/2 Dividend
10/22/2026
Ex-Dividend for 11/2 Dividend
10/22/2026
Dividend Payable
11/02/2026
Last Earnings
11/04/2026
Today
11/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NYSE:CVS
CIK
64803
Employees
300,000
Year Founded
1963

Price Target and Rating

High Price Target
$118.00
Low Price Target
$92.00
Potential Upside/Downside
+20.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.92
Research Coverage
25 Analysts

Profitability

EPS (Trailing Twelve Months)
$8.59
Trailing P/E Ratio
10.40
Forward P/E Ratio
10.34
P/E Growth
0.78
Net Income
$1.77 billion
Net Margins
2.62%
Pretax Margin
2.88%
Return on Equity
13.65%
Return on Assets
4.20%

Debt

Debt-to-Equity Ratio
0.71
Current Ratio
0.85
Quick Ratio
0.66

Sales & Book Value

Annual Sales
$402.07 billion
Price / Sales
0.28
Cash Flow
$14.89 per share
Price / Cash Flow
6.00
Book Value
$59.38 per share
Price / Book
1.51

Miscellaneous

Outstanding Shares
1,279,470,000
Free Float
1,268,598,000
Market Cap
$114.34 billion
Optionable
Optionable
Beta
0.58

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NYSE:CVS) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners